These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38417091)

  • 1. Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3.
    Jaiyesimi IA; Leighl NB; Ismaila N; Alluri K; Florez N; Gadgeel S; Masters G; Schenk EL; Schneider BJ; Sequist L; Singh N; Bazhenova L; Blanchard E; Freeman-Daily J; Furuya N; Halmos B; Azar IH; Kuruvilla S; Mullane M; Naidoo J; Reuss JE; Spigel DR; Owen DH; Patel JD
    J Clin Oncol; 2024 Apr; 42(11):e1-e22. PubMed ID: 38417091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3.
    Jaiyesimi IA; Leighl NB; Ismaila N; Alluri K; Florez N; Gadgeel S; Masters G; Schenk EL; Schneider BJ; Sequist L; Singh N; Bazhenova L; Blanchard E; Freeman-Daily J; Furuya N; Halmos B; Azar IH; Kuruvilla S; Mullane M; Naidoo J; Reuss JE; Spigel DR; Owen DH; Patel JD
    J Clin Oncol; 2024 Apr; 42(11):e23-e43. PubMed ID: 38417098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.1.
    Owen DH; Ismaila N; Freeman-Daily J; Roof L; Singh N; Velazquez AI; Leighl NB
    J Clin Oncol; 2024 Jul; 42(20):e44-e59. PubMed ID: 38815183
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
    Hanna NH; Robinson AG; Temin S; Baker S; Brahmer JR; Ellis PM; Gaspar LE; Haddad RY; Hesketh PJ; Jain D; Jaiyesimi I; Johnson DH; Leighl NB; Moffitt PR; Phillips T; Riely GJ; Rosell R; Schiller JH; Schneider BJ; Singh N; Spigel DR; Tashbar J; Masters G
    J Clin Oncol; 2021 Mar; 39(9):1040-1091. PubMed ID: 33591844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline.
    Daly ME; Singh N; Ismaila N; Antonoff MB; Arenberg DA; Bradley J; David E; Detterbeck F; Früh M; Gubens MA; Moore AC; Padda SK; Patel JD; Phillips T; Qin A; Robinson C; Simone CB
    J Clin Oncol; 2022 Apr; 40(12):1356-1384. PubMed ID: 34936470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update.
    Kris MG; Gaspar LE; Chaft JE; Kennedy EB; Azzoli CG; Ellis PM; Lin SH; Pass HI; Seth R; Shepherd FA; Spigel DR; Strawn JR; Ung YC; Weyant M
    J Clin Oncol; 2017 Sep; 35(25):2960-2974. PubMed ID: 28437162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
    Hanna NH; Schneider BJ; Temin S; Baker S; Brahmer J; Ellis PM; Gaspar LE; Haddad RY; Hesketh PJ; Jain D; Jaiyesimi I; Johnson DH; Leighl NB; Phillips T; Riely GJ; Robinson AG; Rosell R; Schiller JH; Singh N; Spigel DR; Stabler JO; Tashbar J; Masters G
    J Clin Oncol; 2020 May; 38(14):1608-1632. PubMed ID: 31990617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.
    Schneider BJ; Daly ME; Kennedy EB; Antonoff MB; Broderick S; Feldman J; Jolly S; Meyers B; Rocco G; Rusthoven C; Slotman BJ; Sterman DH; Stiles BM
    J Clin Oncol; 2018 Mar; 36(7):710-719. PubMed ID: 29106810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plain language summary and patient perspective of the American Society for Clinical Oncology guideline: management of stage 3 non-small-cell lung cancer.
    Jenkins R; Walker J; Basu Roy U
    Future Oncol; 2024; 20(24):1723-1732. PubMed ID: 36935639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline.
    Khurshid H; Ismaila N; Bian J; Dabney R; Das M; Ellis P; Feldman J; Hann C; Kulkarni S; Laskin J; Manochakian R; Mishra DR; Preeshagul I; Reddy P; Saxena A; Weinberg F; Kalemkerian GP
    J Clin Oncol; 2023 Dec; 41(35):5448-5472. PubMed ID: 37820295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline.
    Schneider BJ; Ismaila N; Aerts J; Chiles C; Daly ME; Detterbeck FC; Hearn JWD; Katz SI; Leighl NB; Levy B; Meyers B; Murgu S; Nekhlyudov L; Santos ES; Singh N; Tashbar J; Yankelevitz D; Altorki N
    J Clin Oncol; 2020 Mar; 38(7):753-766. PubMed ID: 31829901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
    Hanna N; Johnson D; Temin S; Baker S; Brahmer J; Ellis PM; Giaccone G; Hesketh PJ; Jaiyesimi I; Leighl NB; Riely GJ; Schiller JH; Schneider BJ; Smith TJ; Tashbar J; Biermann WA; Masters G
    J Clin Oncol; 2017 Oct; 35(30):3484-3515. PubMed ID: 28806116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Stage III Non-Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update.
    Daly ME; Singh N; Ismaila N;
    J Clin Oncol; 2024 Sep; 42(25):3058-3060. PubMed ID: 39042842
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.1.
    Singh N; Jaiyesimi IA; Ismaila N; Leighl NB; Mamdani H; Phillips T; Owen DH
    J Clin Oncol; 2023 May; 41(15):e42-e50. PubMed ID: 37023367
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.2.
    Owen DH; Singh N; Ismaila N; Masters G; Riely GJ; Robinson AG; Schneider BJ; Jaiyesimi IA
    J Clin Oncol; 2023 Aug; 41(24):e63-e72. PubMed ID: 37433095
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.1.
    Singh N; Jaiyesimi IA; Ismaila N; Leighl NB; Mamdani H; Phillips T; Owen DH
    J Clin Oncol; 2023 May; 41(15):e51-e62. PubMed ID: 37023387
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.
    Kindler HL; Ismaila N; Armato SG; Bueno R; Hesdorffer M; Jahan T; Jones CM; Miettinen M; Pass H; Rimner A; Rusch V; Sterman D; Thomas A; Hassan R
    J Clin Oncol; 2018 May; 36(13):1343-1373. PubMed ID: 29346042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline.
    Chen YP; Ismaila N; Chua MLK; Colevas AD; Haddad R; Huang SH; Wee JTS; Whitley AC; Yi JL; Yom SS; Chan ATC; Hu CS; Lang JY; Le QT; Lee AWM; Lee N; Lin JC; Ma B; Morgan TJ; Shah J; Sun Y; Ma J
    J Clin Oncol; 2021 Mar; 39(7):840-859. PubMed ID: 33405943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
    Masters GA; Temin S; Azzoli CG; Giaccone G; Baker S; Brahmer JR; Ellis PM; Gajra A; Rackear N; Schiller JH; Smith TJ; Strawn JR; Trent D; Johnson DH;
    J Clin Oncol; 2015 Oct; 33(30):3488-515. PubMed ID: 26324367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline.
    Singh N; Temin S; Baker S; Blanchard E; Brahmer JR; Celano P; Duma N; Ellis PM; Elkins IB; Haddad RY; Hesketh PJ; Jain D; Johnson DH; Leighl NB; Mamdani H; Masters G; Moffitt PR; Phillips T; Riely GJ; Robinson AG; Rosell R; Schiller JH; Schneider BJ; Spigel DR; Jaiyesimi IA
    J Clin Oncol; 2022 Oct; 40(28):3323-3343. PubMed ID: 35816668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.